In lung tumour lysates MLN0128 monotherapy causes robust inhibition of HIF1α and GLUT1, translating to a significant and maintained reduction in lung tumour FDG avidity and suppression of tumour growth. This evidence concerns the gene SLC2A1 and neoplasm.